Mexico BE – add-on design? [Regulatives / Guidelines]

posted by nobody – 2014-10-24 10:46 (4264 d 18:07 ago) – Posting: # 13794
Views: 9,894

Hi Risherd!

Nice to meet you, even if it's only on the virtual level!

Good to know that I'm not alone searching for the modified release guidance.

Even better to know that the guidance is a law (must be a law, I guess, otherwise no way to demand performing BE trials inside Mexico), I had some guys wanting to change the model for ANOVA, gives me even more arguments for sticking to the approach given in the guideline. :-D

In general the Mexican guidance is straight forward regarding various topics, but this add-on gives me some headaches. Do you have any experience on that? Does it have to be proposed in the initial protocol? Guess: yes, otherwise no way to preserve the consumer risk. Which statistics are accepted to keep the consumers risk at 5%?

Would be very interesting to know!

Best regards (rain, 9°C, brrrrr...)

nobody

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
227 visitors (0 registered, 227 guests [including 29 identified bots]).
Forum time: 04:53 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5